tirzepatide in the news FDA Grants a New Indication for Obesity Management Diabetes drugs semaglutide and tirzepatide

The effort required to eat less disappears because the desire to eat more simply is not there

Nature 485 , 251255

As mentioned, semaglutide slows down digestion and increases feelings of fullness after eating, which results in the patient consuming less food, thus less calories, which drives weight loss

When it comes to our health, understanding the intricate balance of our bodys systems is crucial

However, clinical trials also reveal that patient experiences vary widely

Even as the obesity and cardiovascular-safety studies reach primary completion, the full analysis, publication, and regulatory review of these datasets remain in progress